1Ames RS,Sarau HM,Chambers JK,et al.Human urotensin-Ⅱ is a potent vasocontrictor and agonist for the orphan receptor GPR14[J].Nature,1999,401(6750):282-286.
2Russell FD,Molenaar P,O'Brien DM.Cardiostimulant effect of urotensin Ⅱ in human heart in vitro[J].Br J Pharmacol,2001,132(1):5-9.
3Douglas SA,Ohlstein EH.Human urotensin Ⅱ,the most potent mammalian vasoconstrictor identified to date,as a therapeutic target for the management of cardiovascular disease[J].Trends Cardiovasc Med,2000,10(6):229-237.
1[1]Coulouarn Y, Lihrman I, Jegou S, Anouar Y, Tostivint H, Beauvillain JC, Conlon JM, Bern HA, Vaudry H. Cloning of cDNA encoding the urotensinⅡprecursor in frog and human reveals intense expression of the urotensinⅡgene in motoneurons of the spinal cord. Proc Natl Acad Sci USA, 1998, 95:15803～15808.
2[2]Ames RS, Sarau HM, Chambers JK, Willette RN, Aiyar NV, Romanic AN, Louden CS, Foley JJ, Sauermelch CF, Coatney RW, Ao Z, Disa J, Holmes SD, Stadel JM, Martin JD, Liu WS, Glover GI, Wilson S, Mcnulty DE, Ellis CE, Elshouragy NA, Shabon U, Trill JJ, Hay DWP, Ohlstein EH, Bergsma DJ, Douglas SA. Human urotensin-Ⅱis a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature, 1999, 401(6750):282～286.
3[3]Russell FD, Molenaar P, O′Brien DM. Cardiostimulant effects of urotensin-Ⅱin human heart in vitro. Br J Pharmacol, 2001,132:5～9.
4[4]Douglas SA,Ohlstein EH.Human urotensin-Ⅱ,the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease. Trends Cardiovasc Med, 2000, 10:229～237.
5[5]Kumar A, Brar R, Wang P, Dee L, Skorupa G, Khadour F, Schulz R, Parrillo JE. Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility. Am J Physiol, 1999,276(1 Pt 2):R265～R276.
6[6]Maclean MR, Alexander D, Seirrar A, Gallagher M, Douglas SA, Ohlstein EH, Morecroft I, Pollard K. Contractile responses to human urotensin-Ⅱin rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat. Br J Pharmacol, 2000,130:201～204.
7[7]Gray GA, Jones MR, Sharif I. Human urotensinⅡ increases coronary perfusion pressure in the isolated rat heart: potentiation by nitric oxide synthase and cyclooxygenase inhibition. Life Sci, 2001,69:175～180.
8[8]Katano Y, Ishihata A, Aita T, Ogaki T, Horie T. Vasodilator effect of urotensinⅡ, one of the most potent vasoconstricting factors, on rat coronary arteries. Eur J Pharmacol, 2000,402(1-2):R5～R7.
9[9]Douglas SA, Sulpizio AC, Piercy V, Sarau HM, Ames RS, Aiyar NV, Ohlstein EH, Willette RN. Differential vasoconstrictor activity of human urotensin-Ⅱ in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey. Br J Pharmacol, 2000,131:1262～1274.
10[10]Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science, 1992,257:387～389.
9Coulouam Y, Lihrmann I, Jegou S,et al. Cloning of the cDNA encoding the urotensin Ⅱ precusor in flog and human reveals intense expression of the urotensin Ⅱ gene in motoneurons of the spinal cord [J]. proc Natl Acad Sci USA, 1998 ;95(26):15803.
10Ames RS,Sarau HM, chambers JK,et al,Human urotensinⅡ is a protent Vasoconstrictor and agonist for the orphan receptor GPR14 [J].Nature, 1999;401(6750):282.
